Versant Capital Management’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-1,499
| Closed | -$29K | – | 1748 |
|
|
2018
Q1 | $29K | Sell |
1,499
-100
| -6% | -$1.94K | 0.01% | 478 |
|
|
2017
Q4 | $26K | Sell |
1,599
-1,078
| -40% | -$17.5K | 0.01% | 551 |
|
|
2017
Q3 | $54K | Buy |
2,677
+1,248
| +87% | +$25.2K | 0.03% | 243 |
|
|
2017
Q2 | $23K | Buy |
1,429
+1,404
| +5,616% | +$22.6K | 0.01% | 546 |
|
|
2017
Q1 | $0 | Hold |
25
| – | – | ﹤0.01% | 1623 |
|
|
2016
Q4 | $0 | Sell |
25
-63
| -72% | – | ﹤0.01% | 1618 |
|
|
2016
Q3 | $2K | Sell |
88
-13
| -13% | -$295 | ﹤0.01% | 1237 |
|
|
2016
Q2 | $2K | Sell |
101
-4
| -4% | -$79 | ﹤0.01% | 1202 |
|
|
2016
Q1 | $3K | Sell |
105
-331
| -76% | -$9.46K | ﹤0.01% | 1101 |
|
|
2015
Q4 | $18K | Buy |
+436
| New | +$18K | 0.01% | 543 |
|